Benidipine
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
O5-methyl O3-[(3R)-1-(phenylmethyl)piperidin-3-yl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status | ? |
Routes | Oral |
Identifiers | |
CAS number | 105979-17-7 |
ATC code | C08CA15 |
PubChem | CID 656668 |
ChemSpider | 571013 |
UNII | 4G9T91JS7E |
Chemical data | |
Formula | C28H31N3O6 |
SMILES
| |
| |
(what is this?) (verify) | |
Benidipine (INN), also known as Benidipinum or benidipine hydrochloride, is a dihydropyridine calcium channel blocker for the treatment of high blood pressure (hypertension).
Dosing
Benidipine is dosed as 2–4 mg once daily.[1]
Availability
Benidipine is sold as Coniel by Kyowa Hakko Kogyo.
Benidipine is only licensed for use in Japan and selected Southeast Asian countries, where it is sold as 4 mg tablets.
References
- ↑ Hi-Eisai Pharmaceutical, Inc. "Coniel (benidipine) package insert (Philippines)". MIMS Philippines. CMPMedica. Retrieved 2008-03-31.
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.